• Mr. Sonu bhagwan tandale
• Mr. Aniket chandrashekhar suryawanshi
• Ms. Sadhana Ramchandra Bamane
• Mr. Omprakash jadhav
• Dr. Ismail S. Pasha

In India, a COVID-19 immunization campaign is presently underway. India completed the world's largest vaccination programme against the corona virus illness (COVID-19) for approximately 300 million priority groups on January 16, 2021, and rolled out the world's largest immunization movement. People were amazed as to why so many people were unaware of the distinctions between these two vaccines, despite the government's efforts to hold on to trust and motivate people to take the COVAXIN and COVISHIELD vaccines, both of which were developed in India for COVID-19. However, preliminary studies revealed that both the Indian and Chinese vaccines were efficacious and safe in the first phase of the vaccination campaign. Both the Indian vaccinations have since received Emergency Use Authorization (EUA) from the Drugs Controller, the regulatory agency and the producers in India's DCGI are keeping an eye on the regulatory guidelines of the vaccine development and the ability to swiftly detect and act on any new safety information and post-treatment adverse events of COVID-19. We screened a large group of people who have been immunized with both doses of COVID-19 at Nesari village and nearby villages (all volunteers over the age of 18). The collected data was analyzed for volunteers immunized with both types of vaccines, viz., COVISHILD and COVAXIN. We concluded by screening 25 Covishield and Covaxin users aged 18 to 25. Based on patient profiles after treatment, we came to know which vaccine has a superior profile. Vaccines have shown different profiles with regard to side effects, age and gender related effects.

Pharmacovigilance, COVID-19, Adverse Drug events, Covishield, Covaxin.

"PHARMACOVIGILANCE: A COMPARATIVE STUDY REGARDING SIDE EFFECTS OF COVISHIELD AND COVAXIN AT A GADHINGLAJ RURAL AREAS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 6, page no.d515-d527, June-2022, Available :http://www.jetir.org/papers/JETIR2206367.pdf

"PHARMACOVIGILANCE: A COMPARATIVE STUDY REGARDING SIDE EFFECTS OF COVISHIELD AND COVAXIN AT A GADHINGLAJ RURAL AREAS", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 6, page no. ppd515-d527, June-2022, Available at : http://www.jetir.org/papers/JETIR2206367.pdf